MedPath

Acne Treatment With Active Oplon's Patches

Phase 2
Completed
Conditions
Acne Vulgaris
Interventions
Device: Oplon Active Patch
Device: Placebo Patch
Registration Number
NCT01180543
Lead Sponsor
Oplon-Pure Science Ltd.
Brief Summary

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Detailed Description

Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Acne Vulgaris
  • Over 18 years
  • Signing informed consent
Exclusion Criteria
  • Active treatment of acne
  • Change in hormonal therapy
  • Antibiotic treatment in a week prior to the experiment
  • Sensitive skin
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active Comparator: Oplon Active PatchOplon Active Patch-
Placebo Comparator: Placebo patchPlacebo Patch-
Primary Outcome Measures
NameTimeMethod
Severity Score of lesionSeverity Score of lesion [Time Frame: 24 hours following patch removal]

Lesions were ranked by investigator according to severity whereas:

0-clear, 1-mild, 2-moderate, 3-sever

Secondary Outcome Measures
NameTimeMethod
Severity Score of lesionSeverity Score of lesion [Time Frame: 12 hours with the patch]

Lesions were ranked by investigator according to severity whereas:

0-clear, 1-mild, 2-moderate, 3-sever

Trial Locations

Locations (1)

Dermatology Clinic

🇮🇱

Natanya, Israel

© Copyright 2025. All Rights Reserved by MedPath